Safety of a single dose of HC022 in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This trial tests a single dose of an investigational drug called HC022 in healthy volunteers to see how safe it is and how the body handles it. If you are a healthy adult, you may be able to join and help researchers learn the first steps about this new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your BMI is between 19 and 28.
- You are generally healthy, with no serious medical conditions or infections.
- You have not participated in another trial in the last 3 months.
- You are willing to use effective birth control during the study and for several months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ACT100 in healthy people to see if it is safe and how the body processes it. It may help find the right dose for future studies.
This early-stage trial tests whether HN2302, a new type of genetic medicine, is safe and helps patients with lupus or systemic sclerosis. Researchers want to see if it can reduce symptoms and improve organ function in people with these autoimmune conditions.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This study tests a new injectable drug, HC022, for people with lupus or cutaneous lupus. It aims to see if the drug is safe, tolerable, and begins to work.
This study tests a new investigational drug called SCTB35 for people with active systemic lupus erythematosus (SLE or lupus). It aims to see if the drug is safe and effective in controlling lupus activity when added to your current stable lupus medications.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.